The University of Chicago Header Logo

Ezra Cohen

Concepts (650)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
120
2022
1035
21.410
Why?
Carcinoma, Squamous Cell
87
2022
1046
15.200
Why?
Antineoplastic Combined Chemotherapy Protocols
58
2022
2348
7.060
Why?
Neoplasm Recurrence, Local
45
2022
1223
6.870
Why?
Antineoplastic Agents
49
2022
2277
6.490
Why?
Quinazolines
28
2019
217
6.280
Why?
ErbB Receptors
29
2021
475
4.850
Why?
Protein Kinase Inhibitors
26
2021
558
4.240
Why?
Antibodies, Monoclonal, Humanized
23
2022
897
4.080
Why?
Thyroid Neoplasms
14
2016
381
3.870
Why?
Mouth Neoplasms
16
2022
189
3.530
Why?
Chemoradiotherapy
21
2022
296
3.100
Why?
Cetuximab
15
2022
114
3.020
Why?
Indazoles
8
2015
69
2.270
Why?
Imidazoles
8
2015
161
2.150
Why?
Humans
208
2022
80814
2.120
Why?
Disease-Free Survival
36
2021
1183
2.090
Why?
Neoplasms
24
2021
2684
2.060
Why?
Papillomavirus Infections
10
2022
234
1.930
Why?
Biomarkers, Tumor
16
2020
1409
1.890
Why?
Oropharyngeal Neoplasms
6
2018
122
1.850
Why?
Aged
93
2021
17464
1.840
Why?
B7-H1 Antigen
8
2022
223
1.740
Why?
Methotrexate
9
2019
247
1.690
Why?
Immunotherapy
9
2021
569
1.680
Why?
Middle Aged
92
2022
23934
1.640
Why?
Sirolimus
8
2018
165
1.590
Why?
TOR Serine-Threonine Kinases
10
2021
181
1.560
Why?
Female
113
2022
42421
1.510
Why?
Male
104
2022
39380
1.420
Why?
Aged, 80 and over
44
2021
6211
1.420
Why?
Antineoplastic Agents, Immunological
7
2020
180
1.410
Why?
Anilides
6
2016
45
1.410
Why?
Indoles
9
2016
313
1.410
Why?
Programmed Cell Death 1 Receptor
7
2022
147
1.400
Why?
Treatment Outcome
54
2021
7467
1.380
Why?
Adult
80
2022
24602
1.370
Why?
Pyridines
8
2016
299
1.320
Why?
Neoplasm Metastasis
21
2021
1036
1.310
Why?
Quality of Life
13
2021
1392
1.250
Why?
Carcinoma, Papillary
4
2016
150
1.200
Why?
Cisplatin
9
2022
593
1.200
Why?
Protein-Tyrosine Kinases
6
2012
300
1.150
Why?
Everolimus
4
2022
39
1.140
Why?
Neoplasm Staging
26
2019
1886
1.130
Why?
Molecular Targeted Therapy
11
2021
258
1.040
Why?
Drug Resistance, Neoplasm
7
2019
561
1.000
Why?
Combined Modality Therapy
25
2020
1615
0.990
Why?
Induction Chemotherapy
11
2021
143
0.970
Why?
Lung Neoplasms
10
2017
2169
0.970
Why?
Papillomaviridae
7
2017
151
0.940
Why?
Iodine Radioisotopes
4
2016
120
0.930
Why?
Mutation
19
2022
3792
0.930
Why?
Salivary Gland Neoplasms
4
2020
64
0.930
Why?
Antibodies, Monoclonal
10
2021
1352
0.900
Why?
Skin Neoplasms
3
2022
512
0.890
Why?
Carcinoma, Non-Small-Cell Lung
8
2017
1019
0.890
Why?
Radiopharmaceuticals
2
2015
159
0.880
Why?
Proto-Oncogene Proteins c-akt
7
2016
309
0.870
Why?
Phenylurea Compounds
6
2015
108
0.860
Why?
Survival Analysis
20
2020
1513
0.840
Why?
Disease Management
4
2021
317
0.810
Why?
Cell Line, Tumor
16
2021
2324
0.780
Why?
Nasopharyngeal Neoplasms
3
2015
44
0.760
Why?
Laryngeal Neoplasms
4
2013
88
0.750
Why?
Prognosis
21
2021
3540
0.750
Why?
Patient Selection
8
2021
661
0.740
Why?
Cancer Vaccines
1
2020
154
0.730
Why?
Signal Transduction
17
2021
3147
0.710
Why?
Antigens, Neoplasm
1
2020
317
0.700
Why?
Diarrhea
4
2014
174
0.690
Why?
Human papillomavirus 16
4
2019
36
0.690
Why?
Kaplan-Meier Estimate
9
2018
839
0.690
Why?
Vascular Endothelial Growth Factor A
5
2014
373
0.680
Why?
Benzazepines
1
2018
87
0.680
Why?
Proto-Oncogene Proteins c-kit
2
2015
79
0.670
Why?
Survivors
2
2016
209
0.650
Why?
Quinolines
2
2015
89
0.650
Why?
Angiogenesis Inhibitors
7
2015
296
0.640
Why?
Clinical Trials as Topic
10
2016
1141
0.640
Why?
Clinical Protocols
2
2014
153
0.630
Why?
Fluorouracil
15
2014
548
0.630
Why?
Research Design
5
2014
566
0.620
Why?
Survival Rate
12
2016
1813
0.620
Why?
Precision Medicine
4
2021
363
0.620
Why?
Killer Cells, Natural
2
2017
307
0.610
Why?
Receptor, ErbB-2
5
2017
198
0.610
Why?
Hypopharyngeal Neoplasms
2
2013
15
0.600
Why?
Carcinoma, Adenoid Cystic
2
2015
27
0.600
Why?
Dasatinib
1
2015
35
0.580
Why?
Class I Phosphatidylinositol 3-Kinases
5
2021
50
0.580
Why?
Administration, Oral
9
2017
678
0.570
Why?
Erlotinib Hydrochloride
6
2016
90
0.560
Why?
Tumor Microenvironment
6
2022
336
0.560
Why?
Mice, Nude
8
2016
752
0.560
Why?
Aftercare
1
2016
62
0.560
Why?
Antibody-Dependent Cell Cytotoxicity
1
2015
22
0.560
Why?
Precancerous Conditions
4
2016
191
0.550
Why?
Drug Administration Schedule
8
2018
915
0.550
Why?
Glutamates
2
2012
89
0.540
Why?
Anticarcinogenic Agents
2
2016
70
0.540
Why?
Antibiotics, Antineoplastic
2
2012
108
0.540
Why?
Practice Guidelines as Topic
4
2019
1013
0.540
Why?
Double-Blind Method
7
2021
1774
0.530
Why?
Maximum Tolerated Dose
10
2017
268
0.530
Why?
Adaptor Proteins, Signal Transducing
4
2016
289
0.530
Why?
Guanine
2
2012
206
0.510
Why?
Palliative Care
2
2015
234
0.510
Why?
Radiodermatitis
1
2013
11
0.500
Why?
Mucositis
1
2013
16
0.500
Why?
Neovascularization, Pathologic
3
2015
336
0.500
Why?
Neoplasm Invasiveness
4
2012
516
0.500
Why?
Pyrroles
4
2015
182
0.490
Why?
Food-Drug Interactions
1
2013
18
0.480
Why?
Hot Temperature
1
2013
198
0.470
Why?
Antimetabolites, Antineoplastic
4
2017
235
0.460
Why?
Information Dissemination
1
2013
100
0.460
Why?
Receptors, Vascular Endothelial Growth Factor
5
2014
58
0.460
Why?
Publishing
1
2013
86
0.460
Why?
Disease Progression
10
2020
1432
0.460
Why?
Surveys and Questionnaires
6
2018
2284
0.450
Why?
Hydroxyurea
12
2014
239
0.450
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2011
20
0.440
Why?
Health Status
1
2014
344
0.440
Why?
Clinical Trials, Phase III as Topic
6
2022
159
0.440
Why?
Radiation Tolerance
4
2016
167
0.440
Why?
Carcinoma, Large Cell
1
2011
39
0.430
Why?
Adenocarcinoma, Follicular
1
2012
51
0.430
Why?
Sulfonamides
5
2016
288
0.420
Why?
Periodicals as Topic
1
2013
161
0.420
Why?
Immunologic Factors
3
2021
163
0.420
Why?
Radiation-Sensitizing Agents
2
2012
95
0.420
Why?
Mitogen-Activated Protein Kinases
3
2008
220
0.410
Why?
Bevacizumab
6
2011
269
0.410
Why?
Benzimidazoles
1
2012
135
0.410
Why?
Retreatment
5
2015
106
0.410
Why?
Thyroid Gland
1
2012
261
0.400
Why?
Patient Care Team
1
2013
268
0.400
Why?
Radiotherapy Dosage
10
2016
485
0.390
Why?
Vascular Endothelial Growth Factor Receptor-2
4
2015
77
0.390
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2022
103
0.390
Why?
Receptor Protein-Tyrosine Kinases
2
2011
152
0.380
Why?
Mice
13
2021
10810
0.380
Why?
Proto-Oncogene Proteins c-ret
3
2016
18
0.380
Why?
Clinical Trials, Phase II as Topic
4
2022
170
0.370
Why?
Dose-Response Relationship, Drug
10
2017
1939
0.370
Why?
Fluorodeoxyglucose F18
1
2010
124
0.370
Why?
Randomized Controlled Trials as Topic
6
2022
804
0.370
Why?
Animals
19
2021
25628
0.360
Why?
Protein Kinase C-alpha
1
2009
27
0.360
Why?
Immunohistochemistry
7
2020
1714
0.360
Why?
Young Adult
11
2019
5713
0.350
Why?
Phosphatidylinositol 3-Kinases
3
2015
248
0.350
Why?
Positron-Emission Tomography
1
2010
277
0.350
Why?
Skin
1
2012
542
0.350
Why?
Proto-Oncogene Proteins B-raf
3
2016
131
0.350
Why?
Thalidomide
3
2015
51
0.350
Why?
United States
14
2020
6167
0.340
Why?
ras Proteins
3
2016
127
0.330
Why?
Adenocarcinoma
3
2011
1125
0.330
Why?
Esophageal Neoplasms
3
2017
304
0.330
Why?
Lymphocyte Activation
3
2020
736
0.330
Why?
Pharmacogenetics
1
2012
424
0.330
Why?
Platinum
5
2016
61
0.330
Why?
Radiotherapy
6
2020
325
0.320
Why?
Medical Oncology
3
2018
332
0.320
Why?
Retrospective Studies
16
2020
7532
0.320
Why?
Chemotherapy, Adjuvant
7
2021
447
0.320
Why?
DNA-Binding Proteins
4
2016
1189
0.310
Why?
Triazines
1
2007
45
0.310
Why?
Biopsy
3
2020
1124
0.310
Why?
Protein Kinases
1
2008
204
0.310
Why?
Niacinamide
5
2014
116
0.300
Why?
DNA, Neoplasm
3
2017
266
0.300
Why?
Prospective Studies
6
2022
3915
0.300
Why?
Eating
1
2007
167
0.300
Why?
Genomics
4
2015
649
0.300
Why?
Xenograft Model Antitumor Assays
6
2021
439
0.300
Why?
Time Factors
9
2020
5087
0.300
Why?
Epidermal Growth Factor
1
2006
120
0.290
Why?
Immunotoxins
1
2005
13
0.290
Why?
Ribosomal Protein S6 Kinases, 70-kDa
3
2018
44
0.290
Why?
Oligonucleotides, Antisense
1
2005
68
0.290
Why?
B-Lymphocytes
2
2021
723
0.280
Why?
Deoxycytidine
2
2011
235
0.280
Why?
Tongue Neoplasms
3
2017
52
0.280
Why?
Drug Approval
2
2019
59
0.280
Why?
Tumor Escape
3
2020
48
0.280
Why?
Viral Vaccines
2
2003
42
0.280
Why?
United States Food and Drug Administration
2
2019
119
0.280
Why?
Protein Kinase C
1
2006
270
0.280
Why?
Proto-Oncogene Proteins p21(ras)
2
2020
142
0.280
Why?
Fatigue
3
2016
166
0.270
Why?
Risk Factors
11
2019
5122
0.270
Why?
Vinblastine
2
2002
108
0.270
Why?
Genes, p53
2
2015
109
0.260
Why?
T-Lymphocytes
3
2020
1189
0.260
Why?
Evidence-Based Dentistry
3
2017
10
0.260
Why?
Chromosome Deletion
2
2015
226
0.250
Why?
Receptor, ErbB-3
2
2021
18
0.250
Why?
MicroRNAs
1
2009
510
0.250
Why?
Piperazines
3
2017
261
0.250
Why?
Cell Proliferation
5
2021
1539
0.250
Why?
Mitochondria
1
2007
517
0.250
Why?
Deglutition
3
2013
67
0.240
Why?
Drug Screening Assays, Antitumor
2
2015
77
0.240
Why?
Biomarkers
6
2021
1600
0.240
Why?
MAP Kinase Signaling System
2
2016
188
0.240
Why?
Smoking
5
2014
593
0.240
Why?
Alcohol Drinking
4
2013
258
0.230
Why?
Immunomodulation
2
2021
55
0.230
Why?
Pain Management
2
2015
119
0.230
Why?
Carboplatin
6
2019
281
0.230
Why?
Follow-Up Studies
10
2018
3528
0.230
Why?
Neoplasms, Second Primary
3
2011
247
0.220
Why?
Cell Cycle
3
2010
496
0.220
Why?
Cohort Studies
7
2019
2579
0.220
Why?
Drug Monitoring
2
2019
115
0.220
Why?
Deglutition Disorders
2
2016
99
0.220
Why?
Pemetrexed
2
2012
76
0.210
Why?
Mechanistic Target of Rapamycin Complex 1
1
2021
27
0.210
Why?
Genetic Therapy
2
2012
334
0.210
Why?
Adenoviridae
2
2003
344
0.210
Why?
Clinical Competence
2
2018
720
0.210
Why?
Germany
1
2021
72
0.210
Why?
Benzenesulfonates
3
2011
63
0.210
Why?
Muscle Neoplasms
1
2001
18
0.210
Why?
Gene Deletion
2
2014
327
0.210
Why?
Germ-Line Mutation
2
2022
307
0.210
Why?
Immunogenicity, Vaccine
1
2020
12
0.210
Why?
Taxoids
2
2014
128
0.210
Why?
Immune System
1
2021
88
0.210
Why?
Salvage Therapy
2
2016
228
0.200
Why?
Placebos
1
2021
217
0.200
Why?
Standard of Care
1
2021
86
0.200
Why?
Carcinoma
3
2015
422
0.200
Why?
Vaccines, Subunit
1
2020
55
0.200
Why?
Oncolytic Virotherapy
1
2020
40
0.200
Why?
Doxorubicin
1
2001
280
0.200
Why?
Heterografts
2
2017
90
0.200
Why?
Radiotherapy, Intensity-Modulated
3
2019
181
0.200
Why?
Rimantadine
1
2019
9
0.200
Why?
Paclitaxel
6
2012
451
0.190
Why?
Quinolones
1
2020
56
0.190
Why?
Oncogene Proteins, Viral
1
2019
33
0.190
Why?
Patient Reported Outcome Measures
1
2021
138
0.190
Why?
Clinical Trials, Phase I as Topic
3
2014
147
0.190
Why?
Nomograms
1
2019
26
0.190
Why?
Age Factors
3
2019
1775
0.190
Why?
DNA Mutational Analysis
2
2015
519
0.180
Why?
Decision Support Techniques
1
2020
152
0.180
Why?
Models, Immunological
1
2019
85
0.180
Why?
CTLA-4 Antigen
1
2019
133
0.180
Why?
Blood Pressure
3
2014
1107
0.180
Why?
Drug Synergism
3
2018
299
0.180
Why?
Epithelial Cells
1
2022
617
0.180
Why?
Carcinoma, Neuroendocrine
3
2013
27
0.170
Why?
Palliative Medicine
1
2018
11
0.170
Why?
Biological Products
1
2020
129
0.170
Why?
Genotype
2
2015
1812
0.170
Why?
Chromosomes, Human, Pair 3
2
2015
54
0.170
Why?
Toll-Like Receptor 7
1
2017
6
0.170
Why?
Toll-Like Receptor 9
1
2017
20
0.170
Why?
Risk Assessment
6
2016
2168
0.170
Why?
Administration, Intravenous
1
2017
45
0.170
Why?
Cell Growth Processes
2
2009
79
0.170
Why?
Consensus
1
2019
296
0.160
Why?
Immune Tolerance
2
2019
326
0.160
Why?
Vascular Endothelial Growth Factor Receptor-3
2
2015
24
0.160
Why?
Immunoglobulin G
1
2019
443
0.160
Why?
Transforming Growth Factor alpha
2
2009
48
0.160
Why?
Evidence-Based Medicine
2
2015
417
0.160
Why?
Mouth Mucosa
2
2009
66
0.160
Why?
Confidence Intervals
4
2019
222
0.160
Why?
Urinary Bladder Neoplasms
1
2001
349
0.160
Why?
Macrophages
2
2017
530
0.160
Why?
SOX9 Transcription Factor
1
2016
22
0.160
Why?
Population Surveillance
2
2018
218
0.160
Why?
Circulating Tumor DNA
1
2017
23
0.160
Why?
Pyrazines
2
2022
84
0.160
Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2016
4
0.160
Why?
Mice, Inbred C3H
1
2017
373
0.160
Why?
Gene Expression
2
2014
1272
0.160
Why?
Proto-Oncogenes
1
2016
61
0.160
Why?
DNA Copy Number Variations
2
2015
169
0.160
Why?
Gene Amplification
2
2015
130
0.160
Why?
Metformin
1
2018
114
0.150
Why?
Models, Biological
3
2014
1720
0.150
Why?
Predictive Value of Tests
2
2020
1604
0.150
Why?
Base Sequence
3
2014
2313
0.150
Why?
Tomography, X-Ray Computed
3
2019
2441
0.150
Why?
Accessory Nerve Diseases
1
2016
1
0.150
Why?
Dental Caries
1
2016
4
0.150
Why?
Taste Disorders
1
2016
7
0.150
Why?
Trismus
1
2016
6
0.150
Why?
Vestibular Neuronitis
1
2016
2
0.150
Why?
Mass Screening
2
2012
596
0.150
Why?
Xerostomia
1
2016
9
0.150
Why?
Respiratory Aspiration
1
2016
5
0.150
Why?
Periodontitis
1
2016
6
0.150
Why?
Benzamides
2
2022
220
0.150
Why?
Voice Disorders
1
2016
6
0.150
Why?
Vascular Endothelial Growth Factor Receptor-1
2
2015
89
0.150
Why?
American Cancer Society
1
2016
14
0.150
Why?
Dental Care
1
2016
11
0.150
Why?
Stomatitis
1
2016
30
0.150
Why?
Neck Muscles
1
2016
15
0.150
Why?
Osteonecrosis
1
2016
21
0.150
Why?
Bursitis
1
2016
11
0.150
Why?
In Situ Hybridization, Fluorescence
3
2012
348
0.150
Why?
Dystonia
1
2016
28
0.150
Why?
Pyrimidinones
1
2016
29
0.150
Why?
Peptide Hormones
1
2016
29
0.150
Why?
Pyridones
1
2016
48
0.150
Why?
Drug Evaluation, Preclinical
1
2015
102
0.140
Why?
Proto-Oncogene Proteins
2
2010
646
0.140
Why?
Societies, Medical
1
2019
564
0.140
Why?
Collagen Type I
1
2015
62
0.140
Why?
Peripheral Nervous System Diseases
1
2016
82
0.140
Why?
Matrix Metalloproteinases
1
2015
27
0.140
Why?
Sleep Apnea Syndromes
1
2016
97
0.140
Why?
Pneumonia, Aspiration
1
2014
18
0.140
Why?
Receptors, IgG
1
2015
51
0.140
Why?
Apoptosis
4
2017
1645
0.130
Why?
Sleep Wake Disorders
1
2016
107
0.130
Why?
Proteomics
2
2022
192
0.130
Why?
Multivariate Analysis
3
2019
959
0.130
Why?
Lymphedema
1
2016
74
0.130
Why?
Stomach Neoplasms
1
2017
251
0.130
Why?
Cost-Benefit Analysis
2
2020
422
0.130
Why?
Ubiquitin-Activating Enzymes
1
2014
6
0.130
Why?
Gastroesophageal Reflux
1
2016
111
0.130
Why?
Autophagy-Related Protein 7
1
2014
12
0.130
Why?
Hypothyroidism
1
2016
216
0.130
Why?
Health Promotion
1
2016
154
0.130
Why?
Phosphorylation
2
2018
1095
0.130
Why?
Heterocyclic Compounds, 3-Ring
1
2014
24
0.130
Why?
Neoplasm Grading
1
2015
323
0.130
Why?
Sequestosome-1 Protein
1
2014
22
0.130
Why?
Tumor Virus Infections
1
2014
79
0.130
Why?
Education, Medical, Graduate
1
2018
344
0.130
Why?
Drug Interactions
3
2011
246
0.130
Why?
Anxiety
1
2016
249
0.130
Why?
Focus Groups
1
2014
139
0.130
Why?
Transcription Factors
2
2016
1484
0.130
Why?
Peptide Fragments
1
2016
451
0.130
Why?
Licensure
1
2013
5
0.130
Why?
Quinoxalines
1
2014
49
0.130
Why?
CD8-Positive T-Lymphocytes
1
2017
525
0.130
Why?
Pediatrics
1
2018
336
0.130
Why?
Tissue Array Analysis
1
2014
121
0.130
Why?
Population Groups
1
2013
41
0.120
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2
2013
72
0.120
Why?
DNA Primers
2
2014
536
0.120
Why?
Peer Review
1
2013
23
0.120
Why?
Leukoplakia, Oral
1
2013
10
0.120
Why?
Neoadjuvant Therapy
3
2018
274
0.120
Why?
Aminolevulinic Acid
1
2013
21
0.120
Why?
Breast Neoplasms
2
2017
2764
0.120
Why?
Receptor, ErbB-4
1
2013
5
0.120
Why?
Erythropoiesis
1
2013
50
0.120
Why?
Economics, Pharmaceutical
1
2013
8
0.120
Why?
Regression Analysis
2
2019
586
0.120
Why?
Photosensitizing Agents
1
2013
46
0.120
Why?
Statistics, Nonparametric
3
2009
299
0.120
Why?
Qualitative Research
1
2014
238
0.120
Why?
Interviews as Topic
1
2014
314
0.120
Why?
Area Under Curve
5
2014
325
0.120
Why?
Italy
1
2013
102
0.120
Why?
Magnetics
1
2013
44
0.120
Why?
Colorectal Neoplasms
2
2011
874
0.120
Why?
Genetic Association Studies
1
2015
290
0.120
Why?
Micelles
1
2013
45
0.120
Why?
United Kingdom
1
2013
158
0.120
Why?
Gastrostomy
1
2013
65
0.120
Why?
Stress, Psychological
1
2016
292
0.120
Why?
Citrus paradisi
1
2012
5
0.120
Why?
Photochemotherapy
1
2013
94
0.120
Why?
Antineoplastic Agents, Phytogenic
2
2012
276
0.120
Why?
Ketoconazole
1
2012
25
0.120
Why?
Gene Expression Profiling
3
2014
1328
0.120
Why?
Lymphopenia
1
2012
30
0.120
Why?
Dose-Response Relationship, Radiation
2
2009
189
0.110
Why?
Depression
1
2016
421
0.110
Why?
Sexual Partners
1
2013
89
0.110
Why?
Platinum Compounds
1
2012
29
0.110
Why?
Autophagy
1
2014
142
0.110
Why?
DNA Repair
1
2014
347
0.110
Why?
Biopsy, Needle
1
2012
232
0.110
Why?
Pyrimidines
2
2014
359
0.110
Why?
Intracellular Signaling Peptides and Proteins
1
2014
377
0.110
Why?
Tumor Suppressor Protein p53
1
2014
365
0.110
Why?
Hyperlipidemias
1
2012
94
0.110
Why?
Exanthema
1
2012
30
0.110
Why?
RNA, Viral
1
2013
319
0.110
Why?
Radiography
2
2014
790
0.110
Why?
Peptides
1
2015
615
0.110
Why?
Bibenzyls
1
2011
2
0.110
Why?
Feasibility Studies
2
2019
725
0.110
Why?
RNA, Small Interfering
2
2010
538
0.110
Why?
Lactams, Macrocyclic
1
2011
14
0.110
Why?
Valproic Acid
1
2011
21
0.110
Why?
Benzoquinones
1
2011
27
0.110
Why?
Radiotherapy, Adjuvant
3
2008
287
0.110
Why?
Depsipeptides
1
2011
29
0.110
Why?
Hyperglycemia
1
2012
170
0.110
Why?
Nanoparticles
1
2013
155
0.100
Why?
Hydroxamic Acids
1
2011
47
0.100
Why?
Tracheotomy
1
2011
18
0.100
Why?
Boronic Acids
1
2011
54
0.100
Why?
Bortezomib
1
2011
72
0.100
Why?
In Situ Nick-End Labeling
1
2011
119
0.100
Why?
Imatinib Mesylate
1
2011
122
0.100
Why?
HSP90 Heat-Shock Proteins
1
2011
45
0.100
Why?
Psoriasis
1
2014
229
0.100
Why?
Carbazoles
1
2011
51
0.100
Why?
Histone Deacetylase Inhibitors
1
2011
81
0.100
Why?
Chemoprevention
1
2011
88
0.100
Why?
Oligonucleotides
1
2011
90
0.100
Why?
Cyclin D1
1
2010
80
0.100
Why?
Camptothecin
1
2011
189
0.100
Why?
Neoplasm Transplantation
1
2011
381
0.100
Why?
Sexual Behavior
1
2013
272
0.100
Why?
Speech
1
2010
74
0.100
Why?
Probability
5
2009
344
0.100
Why?
Airway Obstruction
1
2011
108
0.100
Why?
Piperidines
1
2011
175
0.090
Why?
Antigen-Presenting Cells
2
2021
144
0.090
Why?
Cell Cycle Proteins
2
2010
376
0.090
Why?
Thermography
1
2009
11
0.090
Why?
Mass Spectrometry
1
2010
183
0.090
Why?
Transplantation, Heterologous
1
2010
346
0.090
Why?
Biomedical Research
1
2013
348
0.090
Why?
Referral and Consultation
1
2012
303
0.090
Why?
Receptors, Growth Factor
1
2009
52
0.090
Why?
Tumor Cells, Cultured
1
2011
1031
0.090
Why?
Endpoint Determination
1
2009
59
0.090
Why?
Cyclin E
1
2009
27
0.090
Why?
Internship and Residency
1
2018
929
0.090
Why?
Demography
1
2009
159
0.090
Why?
Cell Line
2
2011
2429
0.090
Why?
Radiotherapy, High-Energy
1
2008
49
0.090
Why?
Cell Survival
1
2011
959
0.090
Why?
Adolescent
6
2019
8656
0.090
Why?
Radiosurgery
1
2011
263
0.090
Why?
Oligonucleotide Array Sequence Analysis
1
2010
680
0.080
Why?
Amino Acid Sequence
2
2016
2059
0.080
Why?
Economics, Medical
1
2007
6
0.080
Why?
Research
1
2009
248
0.080
Why?
Drug Packaging
1
2007
7
0.080
Why?
Analysis of Variance
2
2008
895
0.080
Why?
Drug Labeling
1
2007
40
0.080
Why?
Carcinoma, Renal Cell
1
2011
402
0.080
Why?
Molecular Sequence Data
2
2016
3026
0.080
Why?
Polymorphism, Genetic
1
2011
812
0.080
Why?
Benzophenanthridines
1
2006
23
0.080
Why?
DNA, Mitochondrial
1
2007
180
0.080
Why?
Butadienes
1
2006
33
0.080
Why?
Remission Induction
3
2016
692
0.080
Why?
Phenanthridines
1
2006
24
0.080
Why?
DNA
1
2012
1250
0.080
Why?
Alkaloids
1
2006
45
0.080
Why?
Phosphorylcholine
1
2006
28
0.080
Why?
Phenotype
1
2012
2283
0.070
Why?
Polymorphism, Single Nucleotide
1
2015
2303
0.070
Why?
Nitriles
1
2006
140
0.070
Why?
Surgical Flaps
1
2008
245
0.070
Why?
Early Detection of Cancer
3
2017
350
0.070
Why?
Kidney Neoplasms
1
2011
588
0.070
Why?
American Dental Association
2
2017
10
0.070
Why?
Keratinocytes
1
2006
135
0.070
Why?
Preoperative Care
2
2006
382
0.070
Why?
Cyclooxygenase Inhibitors
1
2004
40
0.070
Why?
SEER Program
2
2016
180
0.070
Why?
Proteasome Inhibitors
1
2004
49
0.070
Why?
Enzyme Activation
1
2006
689
0.070
Why?
Hypoxia-Inducible Factor 1
1
2004
42
0.070
Why?
Incidence
3
2017
1534
0.060
Why?
Mouthwashes
1
2003
5
0.060
Why?
Cell Transformation, Neoplastic
1
2006
406
0.060
Why?
Colonic Neoplasms
1
2008
538
0.060
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2004
147
0.060
Why?
Mitogen-Activated Protein Kinase 3
1
2003
68
0.060
Why?
CCAAT-Enhancer-Binding Protein-beta
2
2016
12
0.060
Why?
Intubation, Gastrointestinal
1
2003
28
0.060
Why?
Disease Models, Animal
2
2020
2157
0.060
Why?
Gene Expression Regulation, Neoplastic
2
2019
1163
0.060
Why?
Odds Ratio
2
2018
648
0.060
Why?
Medicare
2
2016
332
0.060
Why?
Infusions, Intravenous
3
2009
429
0.060
Why?
Inflammation
2
2019
839
0.060
Why?
Isotretinoin
1
2002
23
0.060
Why?
Illinois
1
2003
450
0.050
Why?
Sex Factors
2
2014
1020
0.050
Why?
Cytodiagnosis
2
2012
41
0.050
Why?
Interferon-alpha
1
2002
232
0.050
Why?
Antibody Formation
1
2021
168
0.050
Why?
Lymphopoiesis
1
2021
49
0.050
Why?
Urothelium
1
2001
62
0.050
Why?
Structure-Activity Relationship
1
2001
400
0.050
Why?
RAW 264.7 Cells
1
2019
15
0.050
Why?
Nuclear Proteins
1
2004
682
0.050
Why?
Child
3
2018
6538
0.050
Why?
Treatment Adherence and Compliance
1
2019
5
0.050
Why?
Models, Economic
1
2020
60
0.050
Why?
Thinness
1
2019
42
0.050
Why?
Employment
1
2019
49
0.050
Why?
Smokers
1
2019
36
0.050
Why?
Receptors, Cytokine
1
2019
27
0.050
Why?
Veterans
1
2019
59
0.050
Why?
Quality-Adjusted Life Years
1
2020
130
0.050
Why?
Histocompatibility Antigens Class II
1
2019
161
0.050
Why?
Healthy Volunteers
1
2019
133
0.050
Why?
Hospitals, Veterans
1
2018
16
0.050
Why?
Equivalence Trials as Topic
1
2018
5
0.040
Why?
Training Support
1
2018
23
0.040
Why?
Insulin-Like Growth Factor II
1
2018
33
0.040
Why?
Interdisciplinary Studies
1
2018
20
0.040
Why?
Clinical Decision-Making
1
2020
243
0.040
Why?
Organ Specificity
1
2019
253
0.040
Why?
Laryngectomy
1
2018
26
0.040
Why?
Antigen Presentation
1
2019
226
0.040
Why?
Down-Regulation
1
2019
496
0.040
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
192
0.040
Why?
Autoimmunity
1
2019
157
0.040
Why?
Mouth
1
2017
47
0.040
Why?
Enteral Nutrition
1
2018
98
0.040
Why?
Insulin-Like Growth Factor I
1
2018
114
0.040
Why?
HEK293 Cells
1
2019
600
0.040
Why?
Herpesvirus 1, Human
1
2020
243
0.040
Why?
Acrylamides
1
2017
30
0.040
Why?
Diagnostic Tests, Routine
1
2017
57
0.040
Why?
Reference Values
2
2009
659
0.040
Why?
Neck Dissection
2
2008
65
0.040
Why?
MDS1 and EVI1 Complex Locus Protein
1
2016
6
0.040
Why?
Regulatory-Associated Protein of mTOR
1
2016
10
0.040
Why?
Aniline Compounds
1
2017
44
0.040
Why?
Leukocytes, Mononuclear
1
2018
191
0.040
Why?
Proportional Hazards Models
1
2019
824
0.040
Why?
Osteonectin
1
2016
22
0.040
Why?
National Cancer Institute (U.S.)
1
2016
68
0.040
Why?
Program Evaluation
1
2018
288
0.040
Why?
MCF-7 Cells
1
2016
103
0.040
Why?
Decision Making
1
2002
602
0.040
Why?
Financing, Government
1
2016
22
0.040
Why?
Immunoenzyme Techniques
1
2016
299
0.040
Why?
Loss of Heterozygosity
1
2016
84
0.040
Why?
Bayes Theorem
1
2017
331
0.040
Why?
Comorbidity
1
2019
915
0.040
Why?
Snake Venoms
1
2015
10
0.040
Why?
Pilot Projects
1
2018
792
0.040
Why?
Exons
1
2017
441
0.030
Why?
Acid Anhydride Hydrolases
1
2015
13
0.030
Why?
Microfilament Proteins
1
2016
204
0.030
Why?
RNA Interference
1
2016
356
0.030
Why?
Human papillomavirus 18
1
2014
15
0.030
Why?
Cause of Death
1
2016
272
0.030
Why?
Biological Availability
1
2014
91
0.030
Why?
Cell Division
1
2016
688
0.030
Why?
Gene Knockout Techniques
1
2014
76
0.030
Why?
Lymphatic Metastasis
1
2016
467
0.030
Why?
Nonlinear Dynamics
1
2014
75
0.030
Why?
Protein Interaction Maps
1
2014
48
0.030
Why?
Tissue Distribution
1
2014
277
0.030
Why?
Anorexia
1
2014
29
0.030
Why?
Transcription, Genetic
1
2019
1116
0.030
Why?
Metabolic Clearance Rate
1
2014
119
0.030
Why?
Immunoblotting
1
2014
265
0.030
Why?
Calcitonin
1
2013
38
0.030
Why?
Erythrocyte Count
1
2013
23
0.030
Why?
Carcinoembryonic Antigen
1
2013
37
0.030
Why?
Leg
1
2014
133
0.030
Why?
Algorithms
2
2013
1776
0.030
Why?
Cotinine
1
2013
12
0.030
Why?
NF-kappa B
1
2016
422
0.030
Why?
Erythropoietin
1
2013
89
0.030
Why?
Carrier Proteins
1
2016
658
0.030
Why?
HeLa Cells
1
2014
492
0.030
Why?
Microscopy, Atomic Force
1
2013
48
0.030
Why?
Sequence Analysis, RNA
1
2014
204
0.030
Why?
Sensitivity and Specificity
1
2017
1939
0.030
Why?
Pyrazoles
1
2014
148
0.030
Why?
Tolonium Chloride
1
2012
5
0.030
Why?
Herpesvirus 4, Human
1
2013
111
0.030
Why?
Risk Reduction Behavior
1
2013
97
0.030
Why?
Coloring Agents
1
2012
64
0.030
Why?
Saliva
1
2013
114
0.030
Why?
Microscopy, Confocal
1
2013
266
0.030
Why?
Asymptomatic Diseases
1
2012
38
0.030
Why?
Vomiting
1
2014
182
0.030
Why?
Self Report
1
2013
270
0.030
Why?
Supraglottitis
1
2011
3
0.030
Why?
Chemoradiotherapy, Adjuvant
1
2011
34
0.030
Why?
Physical Examination
1
2012
140
0.030
Why?
Neoplasm Proteins
1
2015
530
0.030
Why?
Radiotherapy Planning, Computer-Assisted
1
2012
191
0.030
Why?
Light
1
2012
281
0.030
Why?
Cells, Cultured
1
2016
2772
0.030
Why?
Radiation Dosage
1
2011
224
0.030
Why?
Review Literature as Topic
1
2010
17
0.020
Why?
Cross-Over Studies
1
2011
392
0.020
Why?
Osteoradionecrosis
1
2010
16
0.020
Why?
Postoperative Period
1
2010
285
0.020
Why?
Mercury Compounds
1
2009
1
0.020
Why?
Cadmium Compounds
1
2009
2
0.020
Why?
Mice, Inbred C57BL
1
2016
3052
0.020
Why?
ROC Curve
1
2012
733
0.020
Why?
Hospitalization
1
2014
764
0.020
Why?
Laboratories
1
2009
38
0.020
Why?
Nitrogen
1
2009
64
0.020
Why?
Tight Junctions
1
2010
143
0.020
Why?
Cyclin D
1
2008
13
0.020
Why?
Infant, Newborn
1
2014
2272
0.020
Why?
Gene Dosage
1
2009
206
0.020
Why?
Transcription Factor AP-1
1
2008
65
0.020
Why?
Azoxymethane
1
2008
82
0.020
Why?
Rats, Inbred F344
1
2008
159
0.020
Why?
Cyclins
1
2008
80
0.020
Why?
STAT3 Transcription Factor
1
2008
70
0.020
Why?
Equipment Design
1
2009
400
0.020
Why?
Organ Preservation
1
2008
73
0.020
Why?
Glioblastoma
1
2010
235
0.020
Why?
Infant
1
2014
2928
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
860
0.020
Why?
Technology, Radiologic
1
2008
102
0.020
Why?
Temperature
1
2009
395
0.020
Why?
Proto-Oncogene Proteins c-met
1
2009
197
0.020
Why?
Child, Preschool
1
2014
3522
0.020
Why?
Barrett Esophagus
1
2008
91
0.020
Why?
Transfection
1
2009
885
0.020
Why?
Forecasting
1
2008
305
0.020
Why?
Protein Structure, Tertiary
1
2009
731
0.020
Why?
Body Mass Index
1
2009
743
0.020
Why?
Blotting, Western
1
2008
772
0.020
Why?
p38 Mitogen-Activated Protein Kinases
1
2006
123
0.020
Why?
Phospholipids
1
2006
108
0.020
Why?
Pleural Effusion
1
2004
44
0.020
Why?
Genome, Human
1
2010
740
0.020
Why?
Organoplatinum Compounds
1
2004
94
0.020
Why?
Administration, Topical
1
2003
89
0.020
Why?
RNA, Messenger
1
2010
1930
0.020
Why?
Genome-Wide Association Study
1
2011
1534
0.020
Why?
In Situ Hybridization
1
2003
303
0.010
Why?
Membrane Proteins
1
2010
1159
0.010
Why?
Survival
1
2002
22
0.010
Why?
Severity of Illness Index
1
2008
1683
0.010
Why?
Registries
1
2006
647
0.010
Why?
Rats
1
2008
3904
0.010
Why?
Case-Control Studies
1
2006
1737
0.010
Why?
Magnetic Resonance Imaging
1
2013
3116
0.010
Why?
Cohen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (650)
Explore
_
Co-Authors (58)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_